Hongbo Lu, a Director at Zenas BioPharma, Inc. (ZBIO), acquired 75,000 shares of the company's stock on March 31, 2026. The transaction, valued at approximately $1.50 million, was executed at a price of $20.00 per share.
This purchase represents a significant investment by a key executive. Large insider buys are often interpreted as a signal of strong confidence in a company's future performance and outlook.
The filing also indicates other recent insider buying activity at Zenas BioPharma, including multiple purchases by Leon O. Moulder Jr. during the same period.